The company announced positive Phase 1 results for a subcutaneous formulation of Briumvi, evaluating it against the currently ...

By Dennis Thompson HealthDay ReporterFRIDAY, June 5, 2026 (HealthDay News) — An already available two-pill combo treats ...

Aurobindo Pharma Ltd has received final US FDA approval to manufacture and market tofacitinib tablets, targeting rheumatoid ...

The devices will also help assess superficial vein patterns and contribute to greater clinical efficiency and accuracy.

Granted, tenecteplase is approved by the FDA stateside but has yet to clear Japanese regulators. Study authors noted that the ...

The Federal Capital Territory Administration (FCTA), has provided 48 vein finders and accompanying accessories for distribution to the 14 SHF under the Hospitals Management Board (HMB). Senior Special ...

Grail executives were upbeat on study results for the Galleri multi-cancer early detection test, while ASCO said more ...

At a median 5-year (60.3 months) planned follow-up of the Phase 2b KEYNOTE-942/mRNA-4157-P201 study, intismeran autogene in combination with KEYTRUDA demonstrated a 49% reduction in the risk of ...

Topline results for the fully enrolled open-label study are expected in the second half of 2026.

The case involved simultaneous proceedings by Central and State GST authorities concerning the same tax period and subject matter. The High Court directed both authorities to coordinate and ensure ...

Many studies require intravenous (i.v.) delivery of drugs, depletion agents or other therapeutic agents. In mice, the lateral tail vein is the most common route of administration. Many researchers, ...

Injection (hereinafter 'Cipepofol'), a Class 1 innovative intravenous anesthetic independently developed by Haisco Pharmaceutical Group, has officially received marketing approval from the U.S. Food ...